Market Tracker

02/22 5:16pm ET

Merck & Co Inc (NYSE:MRK)

65.29
Delayed Data
As of 4:01pm ET
 -0.19 / -0.29%
Today’s Change
49.63
Today|||52-Week Range
65.87
+10.91%
Year-to-Date
Cramer: Buyers for Bristol-Myers Are Few and Far Between
7:04pm / TheStreet.com - Paid Partner Content
Incyte's (INCY) Beats on Q4 Earnings, Provides 2017 Outlook
Feb 15 / Zacks.com - Paid Partner Content
Bristol Myers' Future Unsure as Carl Icahn Takes Stake
6:22pm / Zacks.com - Paid Partner Content
Merck's drug failure deals further blow to Alzheimer's theory
Feb 15 / FT.com - Paid Partner Content
House Border Tax Plan Could Make Travel Abroad Cheaper for Americans
3:05pm / TheStreet.com - Paid Partner Content
Merck (MRK) Halts Late Stage Alzheimer Study; Shares Slip
Feb 15 / Zacks.com - Paid Partner Content
Can Carl Icahn Save Bristol Myers Squibb?
Feb 21 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Coca-Cola, Walt Disney, Visa, Boeing and Merck
Feb 13 / Zacks.com - Paid Partner Content
Bristol-Myers Buys Back Shares, Shuffles Board
Feb 21 / TheStreet.com - Paid Partner Content
Dow 30 Stock Roundup: Coca-Cola, Disney, Visa Beat on Earnings
Feb 10 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Alle...
Feb 21 / Zacks.com - Paid Partner Content
Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017
Feb 10 / MotleyFool.com - Paid Partner Content
Better Buy: Pfizer Inc. vs. Merck & Co. Inc.
Feb 21 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: Allergan, GSK Top 4Q Earnings, Praluent Breather for Sanofi
Feb 10 / Zacks.com - Paid Partner Content
US exporters line up behind tax code overhaul
Feb 21 / FT.com - Paid Partner Content
Brakes on the pathway to treating cancer
Feb 09 / FT.com - Paid Partner Content
Clovis, Tesaro Soar on Astrazeneca Phase Three News
Feb 17 / TheStreet.com - Paid Partner Content
Publicis hit by Razorfish impairment and slower US revenues
Feb 09 / FT.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Merck, PNC Financial, Express Scripts, VeriSign an...
Feb 17 / Zacks.com - Paid Partner Content
AstraZeneca: faith healer
Feb 02 / FT.com - Paid Partner Content
Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ
Feb 17 / Zacks.com - Paid Partner Content
Merck hails rise in patient tests for immunotherapy drug Keytruda
Feb 02 / FT.com - Paid Partner Content
Teachers Insurance & Annuity Association Of America Buys JPMorgan Chase, Arch Coal, ....
Feb 16 / GuruFocus News - Paid Partner Content
Pharma stocks rally on Trump pledge to speed drug approvals
Feb 02 / FT.com - Paid Partner Content
Q4 Earnings Season Scorecard & Top Analyst Reports
Feb 16 / Zacks.com - Paid Partner Content
Earnings deluge; Trump diplomacy; Takeover time?
Feb 02 / CNNMoney.com
Health Care ETF Has Been Ailing
Feb 16 / TheStreet.com - Paid Partner Content
 Pharma execs tout 'manufacturing jobs' in front of Trump
Jan 31 / CNNMoney.com
What's Driving Lilly's (LLY) Shares after 2016 Decline?
Feb 16 / Zacks.com - Paid Partner Content
CEOs cheat sheet on how to please Trump
Jan 31 / CNNMoney.com
Alzheimer's Market Suffers Yet Another Blow with Merck Drug Setback
Feb 16 / Zacks.com - Paid Partner Content
Johnson & Johnson's $30B takeover keeps cash overseas
Jan 26 / CNNMoney.com
Another Potential Alzheimer's Disease Treatment Bites the Dust: What's Next?
Feb 15 / MotleyFool.com - Paid Partner Content